This study is testing whether adding a new drug called zilebesiran can help lower blood pressure in patients who have high cardiovascular risk and whose hypertension is not well controlled by current medications. Participants are randomly assigned to receive either zilebesiran or a placebo, and the study aims to determine if zilebesiran is effective and safe as an additional treatment.